Health-state utility values and their time to deterioration in informal caregivers of older patients with chronic diseases
Bibliographic Data
| ID | 22076192 |
|---|---|
| Authors | Astrid Pozet (0000-0003-4371-1112, Centre Hospitalier Universitaire de Besançon), Antoine Falcoz (Inserm), Cécile Roller (Centre Hospitalier Universitaire de Besançon), Taha Jai (Centre Hospitalier Universitaire de Besançon), Aurelia Meurisse (Inserm), Virginie Nerich (0000-0002-0351-6040, Inserm, corresponding author) |
| Year | 2025 |
| Volume | 13 |
| Pages | 1531608-1531608 |
| Publication date | 2025-04-30 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2025.1531608 |
| PMID | 40371298 |
| OpenAlex | W4409980699 |
| Language | EN |
| References cited | 22 |
Objectives This study aimed to assess health state utility values (HSUVs) in caregivers of older patients with chronic diseases receiving or not receiving social worker support. Methods This multicentric open-label randomized study assigned caregivers to receive either an informational booklet alone or one accompanied by social worker support. Caregivers completed EQ-5D-3L each semester for 24 months. We reported caregiver HSUVs at baseline and after 6, 12, 18, and 24 months using EQ-5D-3L utility index scores and exploring their time to deterioration (TTD). Results Among 179 included caregivers, the percentage reporting some or extreme problems on five EQ-5D-3L dimensions remained almost stable over time with a median EQ-5D-3L utility index score of 0.89 [0.80–1.00] at baseline ( n = 177), 0.80 [0.80–0.89] at M6 ( n = 125), and 0.80 [0.73–0.91] at M24 ( n = 81). Among the respondents, 62% ( n = 109) experienced a deterioration in EQ-5D-3L utility index score, with a median TTD of 9.1 months [95%CI 6.2–14.9] in the control group (CG) and 9.5 months [6.3–14.4] in the supportive intervention group (SIG) (HR = 1.06 [0.73–1.54]), p -value = 0.76. Conclusion Our study provides a catalog of HSUVs across different caregiver profiles and at various follow-up time points, which can inform future economic evaluations. Clinical trial registration ClinicalTrials.gov , NCT02626377
Chronic disease · Intensive care medicine · State of health · Chronic Disease Management Strategies · Dialysis and Renal Disease Management · Health Systems, Economic Evaluations, Quality of Life · Medicine · Gerontology
EuroQol
Health related quality of life in different states of breast cancer
Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Economic costs of informal care for people with chronic diseases in the community
Health effects of informal caregiving across Europe
Understanding the effects of informal caregiving on health and well-being
| Citation velocity | historical |
|---|---|
| Highly cited | No |